KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Figs (FIGS) Cash & Equivalents (2020 - 2025)

Figs (FIGS) has disclosed Cash & Equivalents for 6 consecutive years, with $90.0 million as the latest value for Q1 2025.

  • On a quarterly basis, Cash & Equivalents changed N/A to $90.0 million in Q1 2025 year-over-year; TTM through Mar 2025 was $90.0 million, a N/A change, with the full-year FY2024 number at $85.6 million, down 40.6% from a year prior.
  • Cash & Equivalents was $90.0 million for Q1 2025 at Figs, up from $85.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $195.4 million in Q4 2021 to a low of $73.8 million in Q1 2021.
  • A 5-year average of $139.1 million and a median of $144.2 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 236.08% in 2021, then plummeted 40.6% in 2024.
  • Figs' Cash & Equivalents stood at $195.4 million in 2021, then dropped by 18.22% to $159.8 million in 2022, then fell by 9.76% to $144.2 million in 2023, then tumbled by 40.6% to $85.6 million in 2024, then grew by 5.09% to $90.0 million in 2025.
  • Per Business Quant, the three most recent readings for FIGS's Cash & Equivalents are $90.0 million (Q1 2025), $85.6 million (Q4 2024), and $124.1 million (Q3 2024).